NEUCA S.A. (7HD) Stock Price & Analysis
7HD Stock Chart & Stats
- Day’s Range
- EUR 152.40 - EUR 152.40
- 52-Week Range
- EUR 146.80 - EUR 199.80
- Previous Close
- EUR 152.80
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 730.54M
- Enterprise Value
- EUR 4.11B
- Total Cash (Recent Filing)
- EUR 137.31M
- Total Debt (Recent Filing)
- EUR 797.46M
- Price to Earnings (P/E)
- 16.0
- Beta
- 0.41
- Next Earnings
- Nov 19, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.66%
Bulls Say, Bears Say
Bulls Say
Stable Margins
Stable margins indicate effective cost management and pricing strategies, supporting NEUCA's profitability and operational efficiency over time.
Market Position
As a market leader in pharmaceutical distribution, NEUCA benefits from established relationships and a strong reputation, providing a durable competitive advantage.
Revenue Growth
Consistent revenue growth showcases NEUCA's ability to maintain its market position and adapt to industry demands, ensuring long-term business sustainability.
Bears Say
Earnings Growth
Negative EPS growth reflects challenges in maintaining earnings momentum, which could impact NEUCA's ability to reinvest in its business and sustain shareholder returns.
Profitability Decline
A decline in profitability metrics like ROE may indicate challenges in generating returns from equity, potentially affecting investor confidence and future growth.
Cash Flow Management
Weak cash flow management can limit NEUCA's ability to invest in growth opportunities and meet financial obligations, posing a risk to long-term liquidity.
7HD FAQ
What was NEUCA S.A.’s price range in the past 12 months?
What is NEUCA S.A.’s market cap?
When is NEUCA S.A.’s upcoming earnings report date?
How were NEUCA S.A.’s earnings last quarter?
Is NEUCA S.A. overvalued?
Does NEUCA S.A. pay dividends?
What is NEUCA S.A.’s EPS estimate?
How many shares outstanding does NEUCA S.A. have?
What happened to NEUCA S.A.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of NEUCA S.A.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
NEUCA S.A.
NEUCA S.A., headquartered in Torun, Poland, specializes in supplying pharmaceutical products to pharmacies and healthcare facilities throughout the country. The firm structures its business around distinct segments: wholesale pharmaceutical distribution, the development and marketing of proprietary drug brands, and a comprehensive healthcare services division. This healthcare arm specifically encompasses outpatient care, clinical trials, and telemedicine. Beyond these core areas, NEUCA S.A. provides an extensive array of additional services, including marketing and advertising support, agency functions, financial solutions, logistics through road cargo transport, accounting and bookkeeping, software development, information technology support, and specialized services for hospitals. The company also offers various insurance products—covering health, property, and other personal lines—and operates its own network of medical supply stores. Established in 1990 as Torfarm SA, the company rebranded to NEUCA S.A. in April 2010.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Grzegorz Dzik
- Employees
- 5,004
- Website
- www.neuca.pl/s/?language=pl
- Address
- ul. Forteczna 35-37, Torun, KP, 87-100, PL
NEUCA S.A. (7HD) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 4 | 15 |
| Technical Analysis | 3 | 4 | 3 |
| Moving Averages | 0 | 0 | 12 |

